United States Epithelial Stem Cells Market Report 2016

Market: Pharma & Healthcare

, 123 pages report, published by QYResearch

Report ThumbnailNovember-2016
Notes:
Sales, means the sales volume of Epithelial Stem Cells
Revenue, means the sales value of Epithelial Stem Cells

This report studies sales (consumption) of Epithelial Stem Cells in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
3Dmatrix
Aldagen Inc.
Hybrid Organ Gmbh
Intellicell Biosciences Inc.
Athersys Inc.
Beike Biotechnology Co. Ltd.
Biotime Inc.
Brainstorm Cell Therapeutics Inc.
Gamida Cell Ltd.
Capricor Inc.
Cellerant Therapeutics Inc.
Globalstem
Cellular Dyna
International Stem Cell Corp.
Juventas Therapeutics Inc.
Mesoblast Ltd.
Neuralstem
Neurogeneration
Ocata

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Absorptive cells
Goblet cell
Paneth cells
Oligodendrocytes
Split by applications, this report focuses on sales, market share and growth rate of Epithelial Stem Cells in each application, can be divided into
Tissue repair damage
Autoimmune diseases
Others

  • List of Tables and Figures
  • Figure Picture of Epithelial Stem Cells
  • Table Classification of Epithelial Stem Cells
  • Figure United States Sales Market Share of Epithelial Stem Cells by Type in 2015
  • Figure Absorptive cells Picture
  • Figure Goblet cell Picture
  • Figure Paneth cells Picture
  • Figure Oligodendrocytes Picture
  • Table Application of Epithelial Stem Cells
  • Figure United States Sales Market Share of Epithelial Stem Cells by Application in 2015
  • Figure Tissue repair damage Examples
  • Figure Autoimmune diseases Examples
  • Figure Others Examples
  • Figure United States Epithelial Stem Cells Sales and Growth Rate (2011-2021)
  • Figure United States Epithelial Stem Cells Revenue and Growth Rate (2011-2021)
  • Table United States Epithelial Stem Cells Sales of Key Manufacturers (2015 and 2016)
  • Table United States Epithelial Stem Cells Sales Share by Manufacturers (2015 and 2016)
  • Figure 2015 Epithelial Stem Cells Sales Share by Manufacturers
  • Figure 2016 Epithelial Stem Cells Sales Share by Manufacturers
  • Table United States Epithelial Stem Cells Revenue by Manufacturers (2015 and 2016)
  • Table United States Epithelial Stem Cells Revenue Share by Manufacturers (2015 and 2016)
  • Table 2015 United States Epithelial Stem Cells Revenue Share by Manufacturers
  • Table 2016 United States Epithelial Stem Cells Revenue Share by Manufacturers
  • Table United States Market Epithelial Stem Cells Average Price of Key Manufacturers (2015 and 2016)
  • Figure United States Market Epithelial Stem Cells Average Price of Key Manufacturers in 2015
  • Figure Epithelial Stem Cells Market Share of Top 3 Manufacturers
  • Figure Epithelial Stem Cells Market Share of Top 5 Manufacturers
  • Table United States Epithelial Stem Cells Sales by Type (2011-2016)
  • Table United States Epithelial Stem Cells Sales Share by Type (2011-2016)
  • Figure United States Epithelial Stem Cells Sales Market Share by Type in 2015
  • Table United States Epithelial Stem Cells Revenue and Market Share by Type (2011-2016)
  • Table United States Epithelial Stem Cells Revenue Share by Type (2011-2016)
  • Figure Revenue Market Share of Epithelial Stem Cells by Type (2011-2016)
  • Table United States Epithelial Stem Cells Price by Type (2011-2016)
  • Figure United States Epithelial Stem Cells Sales Growth Rate by Type (2011-2016)
  • Table United States Epithelial Stem Cells Sales by Application (2011-2016)
  • Table United States Epithelial Stem Cells Sales Market Share by Application (2011-2016)
  • Figure United States Epithelial Stem Cells Sales Market Share by Application in 2015
  • Table United States Epithelial Stem Cells Sales Growth Rate by Application (2011-2016)
  • Figure United States Epithelial Stem Cells Sales Growth Rate by Application (2011-2016)
  • Table 3Dmatrix Basic Information List
  • Table 3Dmatrix Epithelial Stem Cells Sales, Revenue, Price and Gross Margin (2011-2016)
  • Figure 3Dmatrix Epithelial Stem Cells Sales Market Share (2011-2016)
  • Table Aldagen Inc. Basic Information List
  • Table Aldagen Inc. Epithelial Stem Cells Sales, Revenue, Price and Gross Margin (2011-2016)
  • Table Aldagen Inc. Epithelial Stem Cells Sales Market Share (2011-2016)
  • Table Hybrid Organ Gmbh Basic Information List
  • Table Hybrid Organ Gmbh Epithelial Stem Cells Sales, Revenue, Price and Gross Margin (2011-2016)
  • Table Hybrid Organ Gmbh Epithelial Stem Cells Sales Market Share (2011-2016)
  • Table Intellicell Biosciences Inc. Basic Information List
  • Table Intellicell Biosciences Inc. Epithelial Stem Cells Sales, Revenue, Price and Gross Margin (2011-2016)
  • Table Intellicell Biosciences Inc. Epithelial Stem Cells Sales Market Share (2011-2016)
  • Table Athersys Inc. Basic Information List
  • Table Athersys Inc. Epithelial Stem Cells Sales, Revenue, Price and Gross Margin (2011-2016)
  • Table Athersys Inc. Epithelial Stem Cells Sales Market Share (2011-2016)
  • Table Beike Biotechnology Co. Ltd. Basic Information List
  • Table Beike Biotechnology Co. Ltd. Epithelial Stem Cells Sales, Revenue, Price and Gross Margin (2011-2016)
  • Table Beike Biotechnology Co. Ltd. Epithelial Stem Cells Sales Market Share (2011-2016)
  • Table Biotime Inc. Basic Information List
  • Table Biotime Inc. Epithelial Stem Cells Sales, Revenue, Price and Gross Margin (2011-2016)
  • Table Biotime Inc. Epithelial Stem Cells Sales Market Share (2011-2016)
  • Table Brainstorm Cell Therapeutics Inc. Basic Information List
  • Table Brainstorm Cell Therapeutics Inc. Epithelial Stem Cells Sales, Revenue, Price and Gross Margin (2011-2016)
  • Table Brainstorm Cell Therapeutics Inc. Epithelial Stem Cells Sales Market Share (2011-2016)
  • Table Gamida Cell Ltd. Basic Information List
  • Table Gamida Cell Ltd. Epithelial Stem Cells Sales, Revenue, Price and Gross Margin (2011-2016)
  • Table Gamida Cell Ltd. Epithelial Stem Cells Sales Market Share (2011-2016)
  • Table Capricor Inc. Basic Information List
  • Table Capricor Inc. Epithelial Stem Cells Sales, Revenue, Price and Gross Margin (2011-2016)
  • Table Capricor Inc. Epithelial Stem Cells Sales Market Share (2011-2016)
  • Table Cellerant Therapeutics Inc. Basic Information List
  • Table Cellerant Therapeutics Inc. Epithelial Stem Cells Sales, Revenue, Price and Gross Margin (2011-2016)
  • Table Cellerant Therapeutics Inc. Epithelial Stem Cells Sales Market Share (2011-2016)
  • Table Globalstem Basic Information List
  • Table Globalstem Epithelial Stem Cells Sales, Revenue, Price and Gross Margin (2011-2016)
  • Table Globalstem Epithelial Stem Cells Sales Market Share (2011-2016)
  • Table Cellular Dyna Basic Information List
  • Table Cellular Dyna Epithelial Stem Cells Sales, Revenue, Price and Gross Margin (2011-2016)
  • Table Cellular Dyna Epithelial Stem Cells Sales Market Share (2011-2016)
  • Table International Stem Cell Corp. Basic Information List
  • Table International Stem Cell Corp. Epithelial Stem Cells Sales, Revenue, Price and Gross Margin (2011-2016)
  • Table International Stem Cell Corp. Epithelial Stem Cells Sales Market Share (2011-2016)
  • Table Juventas Therapeutics Inc. Basic Information List
  • Table Juventas Therapeutics Inc. Epithelial Stem Cells Sales, Revenue, Price and Gross Margin (2011-2016)
  • Table Juventas Therapeutics Inc. Epithelial Stem Cells Sales Market Share (2011-2016)
  • Table Mesoblast Ltd. Basic Information List
  • Table Mesoblast Ltd. Epithelial Stem Cells Sales, Revenue, Price and Gross Margin (2011-2016)
  • Table Mesoblast Ltd. Epithelial Stem Cells Sales Market Share (2011-2016)
  • Table Neuralstem Basic Information List
  • Table Neuralstem Epithelial Stem Cells Sales, Revenue, Price and Gross Margin (2011-2016)
  • Table Neuralstem Epithelial Stem Cells Sales Market Share (2011-2016)
  • Table Neurogeneration Basic Information List
  • Table Neurogeneration Epithelial Stem Cells Sales, Revenue, Price and Gross Margin (2011-2016)
  • Table Neurogeneration Epithelial Stem Cells Sales Market Share (2011-2016)
  • Table Ocata Basic Information List
  • Table Ocata Epithelial Stem Cells Sales, Revenue, Price and Gross Margin (2011-2016)
  • Table Ocata Epithelial Stem Cells Sales Market Share (2011-2016)
  • Table Production Base and Market Concentration Rate of Raw Material
  • Figure Price Trend of Key Raw Materials
  • Table Key Suppliers of Raw Materials
  • Figure Manufacturing Cost Structure of Epithelial Stem Cells
  • Figure Manufacturing Process Analysis of Epithelial Stem Cells
  • Figure Epithelial Stem Cells Industrial Chain Analysis
  • Table Raw Materials Sources of Epithelial Stem Cells Major Manufacturers in 2015
  • Table Major Buyers of Epithelial Stem Cells
  • Table Distributors/Traders List
  • Figure United States Epithelial Stem Cells Production and Growth Rate Forecast (2016-2021)
  • Figure United States Epithelial Stem Cells Revenue and Growth Rate Forecast (2016-2021)
  • Table United States Epithelial Stem Cells Production Forecast by Type (2016-2021)
  • Table United States Epithelial Stem Cells Consumption Forecast by Application (2016-2021)
  • Table of Contents
  • United States Epithelial Stem Cells Market Report 2016
  • 1 Epithelial Stem Cells Overview
  • 1.1 Product Overview and Scope of Epithelial Stem Cells
  • 1.2 Classification of Epithelial Stem Cells
  • 1.2.1 Absorptive cells
  • 1.2.2 Goblet cell
  • 1.2.3 Paneth cells
  • 1.2.4 Oligodendrocytes
  • 1.3 Application of Epithelial Stem Cells
  • 1.3.1 Tissue repair damage
  • 1.3.2 Autoimmune diseases
  • 1.3.3 Others
  • 1.4 United States Market Size Sales (Value) and Revenue (Volume) of Epithelial Stem Cells (2011-2021)
  • 1.4.1 United States Epithelial Stem Cells Sales and Growth Rate (2011-2021)
  • 1.4.2 United States Epithelial Stem Cells Revenue and Growth Rate (2011-2021)
  • 2 United States Epithelial Stem Cells Competition by Manufacturers
  • 2.1 United States Epithelial Stem Cells Sales and Market Share of Key Manufacturers (2015 and 2016)
  • 2.2 United States Epithelial Stem Cells Revenue and Share by Manufactures (2015 and 2016)
  • 2.3 United States Epithelial Stem Cells Average Price by Manufactures (2015 and 2016)
  • 2.4 Epithelial Stem Cells Market Competitive Situation and Trends
  • 2.4.1 Epithelial Stem Cells Market Concentration Rate
  • 2.4.2 Epithelial Stem Cells Market Share of Top 3 and Top 5 Manufacturers
  • 2.4.3 Mergers & Acquisitions, Expansion
  • 3 United States Epithelial Stem Cells Sales (Volume) and Revenue (Value) by Type (2011-2016)
  • 3.1 United States Epithelial Stem Cells Sales and Market Share by Type (2011-2016)
  • 3.2 United States Epithelial Stem Cells Revenue and Market Share by Type (2011-2016)
  • 3.3 United States Epithelial Stem Cells Price by Type (2011-2016)
  • 3.4 United States Epithelial Stem Cells Sales Growth Rate by Type (2011-2016)
  • 4 United States Epithelial Stem Cells Sales (Volume) by Application (2011-2016)
  • 4.1 United States Epithelial Stem Cells Sales and Market Share by Application (2011-2016)
  • 4.2 United States Epithelial Stem Cells Sales Growth Rate by Application (2011-2016)
  • 4.3 Market Drivers and Opportunities
  • 5 United States Epithelial Stem Cells Manufacturers Profiles/Analysis
  • 5.1 3Dmatrix
  • 5.1.1 Company Basic Information, Manufacturing Base and Competitors
  • 5.1.2 Epithelial Stem Cells Product Type, Application and Specification
  • 5.1.2.1 Type I
  • 5.1.2.2 Type II
  • 5.1.3 3Dmatrix Epithelial Stem Cells Sales, Revenue, Price and Gross Margin (2011-2016)
  • 5.1.4 Main Business/Business Overview
  • 5.2 Aldagen Inc.
  • 5.2.2 Epithelial Stem Cells Product Type, Application and Specification
  • 5.2.2.1 Type I
  • 5.2.2.2 Type II
  • 5.2.3 Aldagen Inc. Epithelial Stem Cells Sales, Revenue, Price and Gross Margin (2011-2016)
  • 5.2.4 Main Business/Business Overview
  • 5.3 Hybrid Organ Gmbh
  • 5.3.2 Epithelial Stem Cells Product Type, Application and Specification
  • 5.3.2.1 Type I
  • 5.3.2.2 Type II
  • 5.3.3 Hybrid Organ Gmbh Epithelial Stem Cells Sales, Revenue, Price and Gross Margin (2011-2016)
  • 5.3.4 Main Business/Business Overview
  • 5.4 Intellicell Biosciences Inc.
  • 5.4.2 Epithelial Stem Cells Product Type, Application and Specification
  • 5.4.2.1 Type I
  • 5.4.2.2 Type II
  • 5.4.3 Intellicell Biosciences Inc. Epithelial Stem Cells Sales, Revenue, Price and Gross Margin (2011-2016)
  • 5.4.4 Main Business/Business Overview
  • 5.5 Athersys Inc.
  • 5.5.2 Epithelial Stem Cells Product Type, Application and Specification
  • 5.5.2.1 Type I
  • 5.5.2.2 Type II
  • 5.5.3 Athersys Inc. Epithelial Stem Cells Sales, Revenue, Price and Gross Margin (2011-2016)
  • 5.5.4 Main Business/Business Overview
  • 5.6 Beike Biotechnology Co. Ltd.
  • 5.6.2 Epithelial Stem Cells Product Type, Application and Specification
  • 5.6.2.1 Type I
  • 5.6.2.2 Type II
  • 5.6.3 Beike Biotechnology Co. Ltd. Epithelial Stem Cells Sales, Revenue, Price and Gross Margin (2011-2016)
  • 5.6.4 Main Business/Business Overview
  • 5.7 Biotime Inc.
  • 5.7.2 Epithelial Stem Cells Product Type, Application and Specification
  • 5.7.2.1 Type I
  • 5.7.2.2 Type II
  • 5.7.3 Biotime Inc. Epithelial Stem Cells Sales, Revenue, Price and Gross Margin (2011-2016)
  • 5.7.4 Main Business/Business Overview
  • 5.8 Brainstorm Cell Therapeutics Inc.
  • 5.8.2 Epithelial Stem Cells Product Type, Application and Specification
  • 5.8.2.1 Type I
  • 5.8.2.2 Type II
  • 5.8.3 Brainstorm Cell Therapeutics Inc. Epithelial Stem Cells Sales, Revenue, Price and Gross Margin (2011-2016)
  • 5.8.4 Main Business/Business Overview
  • 5.9 Gamida Cell Ltd.
  • 5.9.2 Epithelial Stem Cells Product Type, Application and Specification
  • 5.9.2.1 Type I
  • 5.9.2.2 Type II
  • 5.9.3 Gamida Cell Ltd. Epithelial Stem Cells Sales, Revenue, Price and Gross Margin (2011-2016)
  • 5.9.4 Main Business/Business Overview
  • 5.10 Capricor Inc.
  • 5.10.2 Epithelial Stem Cells Product Type, Application and Specification
  • 5.10.2.1 Type I
  • 5.10.2.2 Type II
  • 5.10.3 Capricor Inc. Epithelial Stem Cells Sales, Revenue, Price and Gross Margin (2011-2016)
  • 5.10.4 Main Business/Business Overview
  • 5.11 Cellerant Therapeutics Inc.
  • 5.12 Globalstem
  • 5.13 Cellular Dyna
  • 5.14 International Stem Cell Corp.
  • 5.15 Juventas Therapeutics Inc.
  • 5.16 Mesoblast Ltd.
  • 5.17 Neuralstem
  • 5.18 Neurogeneration
  • 5.19 Ocata
  • 6 Epithelial Stem Cells Manufacturing Cost Analysis
  • 6.1 Epithelial Stem Cells Key Raw Materials Analysis
  • 6.1.1 Key Raw Materials
  • 6.1.2 Price Trend of Key Raw Materials
  • 6.1.3 Key Suppliers of Raw Materials
  • 6.1.4 Market Concentration Rate of Raw Materials
  • 6.2 Proportion of Manufacturing Cost Structure
  • 6.2.1 Raw Materials
  • 6.2.2 Labor Cost
  • 6.2.3 Manufacturing Expenses
  • 6.3 Manufacturing Process Analysis of Epithelial Stem Cells
  • 7 Industrial Chain, Sourcing Strategy and Downstream Buyers
  • 7.1 Epithelial Stem Cells Industrial Chain Analysis
  • 7.2 Upstream Raw Materials Sourcing
  • 7.3 Raw Materials Sources of Epithelial Stem Cells Major Manufacturers in 2015
  • 7.4 Downstream Buyers
  • 8 Marketing Strategy Analysis, Distributors/Traders
  • 8.1 Marketing Channel
  • 8.1.1 Direct Marketing
  • 8.1.2 Indirect Marketing
  • 8.1.3 Marketing Channel Development Trend
  • 8.2 Market Positioning
  • 8.2.1 Pricing Strategy
  • 8.2.2 Brand Strategy
  • 8.2.3 Target Client
  • 8.3 Distributors/Traders List
  • 9 Market Effect Factors Analysis
  • 9.1 Technology Progress/Risk
  • 9.1.1 Substitutes Threat
  • 9.1.2 Technology Progress in Related Industry
  • 9.2 Consumer Needs/Customer Preference Change
  • 9.3 Economic/Political Environmental Change
  • 10 United States Epithelial Stem Cells Market Forecast (2016-2021)
  • 10.1 United States Epithelial Stem Cells Sales, Revenue Forecast (2016-2021)
  • 10.2 United States Epithelial Stem Cells Sales Forecast by Type (2016-2021)
  • 10.3 United States Epithelial Stem Cells Sales Forecast by Application (2016-2021)
  • 10.4 Epithelial Stem Cells Price Forecast (2016-2021)
  • 11 Research Findings and Conclusion
  • 12 Appendix
  • Author List
  • Disclosure Section
  • Research Methodology
  • Data Source
  • Disclaimer

Please select a license type

Share

Related Products

QYResearchUnited States Epithelial Stem Cells Market Report 2016 Product ThumbnailUnited States Epithelial Stem Cells Market Report 2016 , Industry Report available for $3800Product #: 600730
GlobalData
TeleResearch
Global Markets Direct
GBI Research
MarketsandMarkets
MicroMarketMonitor
PayPal Acceptance Mark
SSL Certificate
Copyright © 2017 Global Market Analyst. All Rights Reserved